Our data suggest that TIP60 and miR-22 could act as prognostic markers in breast cancer disease progression and that targeting the TIP60–miR-22 axis could lead to an effective therapeutic strategy for metastatic breast cancer. Here, KAT5 is linked to breast carcinoma.